Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content. This indicates the page is temporarily inaccessible and blocks access to the study record.
    Difference
    0.5%
    Check dated 2026-09-26T21:44:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a standard error page to indicate blocked access.
    Difference
    18%
    Check dated 2026-09-19T22:01:18.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record adds an NIH grant/contract attribution for 2017. It also updates the revision tag from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:48:25.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The changes add Revision: v3.6.5 and remove Revision: v3.6.4, indicating a minor update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-08-08T09:46:40.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a new build or template for the page. This is an internal version change rather than a modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-07-25T05:19:13.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.6.3 has been added and the previous Revision: v3.6.2 has been removed. This appears to be a minor update to the page's metadata indicating a small internal change.
    Difference
    0.0%
    Check dated 2026-07-03T14:51:45.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.